KUALA LUMPUR, Jun 18, 2021 - (ACN Newswire via SEAPRWire.com) - Amid rising concerns about the threat and economic impact of COVID-19, Holista Colltech Limited has been granted permission for Special access under the Medical Device (Exemption) Order 2016, from the Medical Devices Authority ("MDA") of Malaysia's Ministry of Health ("MOH") to import and distribute for an antigen rapid test kit (RTK-AG) developed and manufactured by Guangdong Hecin Scientific Inc. ("Hecin") of China. With this approval, the Company has secured an initial order for 15,000 units in Malaysia.Holista Colltech Limited ("Holista"), a natural wellness and health products specialist headquartered in Petaling Jaya and listed on the Australian Securities Exchange ("ASX: HCT"), said the Hecin(TM) 2019-nCOV diagnostic test kits will be used to detect the presence of the SARS-CoV-2 viral antigen from nasal swabs within 15 minutes.Antigen tests look for the coating or proteins of the virus while Polymerase Chain Reaction ("PCR") tests detect its nucleic acid, or genetic material (also known as RNA). The former can deliver results within minutes and generally cost less; the latter, while more accurate, can take up t...